inflammatory'cytokines'TNFα'and'ILS1β'were' also ' observed' in' aged' brains' [19] . ' ' Microglia' also' exhibit' morphological' changes' and' degeneration' during' normal' ageing' leading' to'the'possibility'of'impaired'Aβ'clearance'in' aged' patients,' which' could' lead' to' the' promotion' of' neurodegeneration ' [20] . ' ' This' suggests' that' even' during' normal' ageing' there' is' a' dysregulation' of' microglia' and' associated' immune' responses,' and' that' this' is'increased'during'AD.' ' When' ' microglia' ' come' ' into' ' contact' ' with'' Aβ,' ' they' ' become' ' activated' ' and' ' release'' inflammatory'chemokines'and'cytokines'into' the' local' environment' [21] .' ' Initially,' microglia' are' able' to' clear' Aβ' plaques,' ' but' become'overwhelmed'as'AD'progresses, 'and' release' toxic' cytokines,' chemokines' and' reactive' oxygen' species,' these' agents' act' upon' surrounding' neurons' contributing' to' their'death'[22] .''Aβ'plaques'increase'in'size' and' number' despite' the' presence' of' increased' microglia ' [23] , ' and' ultimately' the' toxic'environment'causes'neuronal'cell'death' and' advancement' of' disease' [24] .' ' Figure' 1' shows' microglia' (stained' red)' around' Aβ' plaques' (stained' green)' in' the' mouse' model' of'AD,'PS1APP,'at'365'days'of'age.' ' Microglial!Aβ!Receptors' ApoE' Variation' in' the' ApoE' (apolipoprotein' E)' allele,'along'with'ageing'in'humans'is'a'major' risk' factor' for' AD.' ApoE' is' the' main' cholesterol' transporter' in' the' brain' and' intracellular'degradation'of'Aβ'by'microglia' was'found'to'be'enhanced'in'the'presence'of' ApoE' [25] .' ' ApoE' expression' is' regulated' by' PPARSγ' (peroxisome' proliferator-activated' receptor'gamma)'and'LXR'(liver'X'receptors)' which'are'ligandSactivated'nuclear'receptors.'' PPARSγ' and' LXR' form' heterodimers' with' retinoid' X' receptors,' these' heterodimers' induce'the'expression'of'ApoE'on'microglia' which'stimulates'their'ability'to'phagocytose' soluble' Aβ. ' ' Agonist' treatment' of' LXR' and' PPARSγ' improved' cognitive' functions' and' reduced'Aβ'levels'in'mouse'brains'[26] .'
Figure! 1.! ! PS1APP' mouse' brain' section' at' 365' days' of' age' (100X' magnification)' stained' for' microglia' (CD11b),' Aβ' plaques' (THIOSS)' and' cell' nuclei' (DAPI),' showing' microglial' accumulation' around'Aβ'plaques'(MERGED).' ' Scavenger!receptors' Microglia'express'various'receptors'for'Aβ'on' their' cell' surface,' including' scavenger' receptors' (SR).' ' The' scavenger' receptors' belong' to' the' family' of' pattern' recognition' receptors' (PRR),' which' also' include' tollSlike' receptors.' ' SR' were' first' described' as' receptors' expressed' on' macrophages' that' bound 'and'internalized'modified'lowSdensity' lipoprotein, ' and' contributed' to' foam' cell' formation'during'atherosclerosis'[27] .''Other' ligands' for' SRs' have' been' discovered' since' then,' and' the' definition' of' scavenger' receptors' has' expanded' to' define' a' large' family 'of'molecules'that'bind'various'self'and' nonS' self' ligands,' and' are' evolutionarily' conserved,' highlighting' their' important' roles' in'innate'defense'against'pathogens.' ' Most!SRs'are'grouped'into'classes'A'through' F,' with' the' receptors' RAGE,' SRSPSOX' and' CD163' remaining' unclassified.' ' Class' A' includes' SCARAS1,' SCARAS2' and' MARCO,' all' of' which' have' a' coiled' coil' domain' believed' to' be' the' ligand' binding' domain' of' these' receptors.' ' The' class' B' receptors' SCARBS1,' SCARBS2'and'CD36'have'an'N'and'C'terminal' membrane' spanning' region' and' a' large' extracellular' loop.' ' SCARC,' the' class' C' receptor' has' been' discovered' in" Drosophila' but' no' mammalian' ortholog' has' been' identified' to' date.' ' CD68,' the' most' well' characterized' class' D' SR' has' a' mucinSlike' domain' and' SCARE' (Class' E' receptors)' includes' LOXS1,' with' a' CStype' lectin' domain.'' SREC,' a' member' of' the' class' F' receptors' is' characterized' by' multiple' epidermal' growthS factor'like'repeats '[28] .' ' Aβ!phagocytosis!by!SCARAK1' SCARAS1' (scavenger' receptor' AS1)' is' a' wellS characterized' multiSligand' binding' receptor.'' SCARAS1' binds' modified' lipoproteins,' lipopolysaccharide'(LPS) '[29] 'and'lipoteichoic' acid' (LTA) ' [30,' 31],' and' also' is' involved' in' phagocytosis'of'bacteria'[31,'32] .' ' SCARAS1' expressed' on' microglia' has' previously' been' shown' to' be' a' receptor' for' Aβ'in'mice'and'humans'whose'function'is'to' facilitate' phagocytosis' of' Aβ' [33] .' SCARAS1' knockSout' microglia' were' greatly ' reduced' in' 13"" """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""Journal"of"Postdoctoral"Research"January"2013":"10821" ' their' ability' to' engulf' Aβ' when' compared' with' cells' isolated' from' wildStype' mice' [34] .'' When' a' SCARAS1' knockSout' mouse' was' crossed' with' a' transgenic' AD' model' mouse,' there' was' surprisingly' no' reduction' in' Aβ' plaque'number'in'the'brains'of'these'animals' [35] .' ' This' study' shows' a' redundancy' in' SCARAS1' function' and' suggests' other' receptors'are'involved'in'clearing'Aβ.' ! Aβ!mediated!inflammation!through!CD36' CD36'is'a'member'of'the'scavenger'receptor' class' B' family,' initially' described' as' a' receptor' for' thrombospondin ' [36] , ' and' for' red' blood' cells' infected' with' malaria' [37] .'' CD36' is' expressed' on' microglia' and' is' a' receptor' for' Aβ' [38] .' ' Aβ' binding' to' CD36' triggers' an' intracellular' signaling' cascade' involving'the'Src'family'members'Fyn'and'Lyn' and'MAPK'(mitogenSactivated'protein'kinase)' activation'which'then'activates'the'microglia' and' leads' to' production' of' cytokines,' chemokines' and' reactive' oxygen' species' (ROS) ' [39] .' ' It' was' recently' shown' that' the' activation'of'CD36'by'Aβ'requires'the'tollSlike' receptors' TLRS4' and' TLRS6;' this' heterotrimeric' complex' activates' the' inflammasome' by' causing' an' increase' in' ILS 1β'mRNA'in'microglia '[40] .' ! Formyl!peptide!receptors' The' formyl' peptide' receptors' (FPR) ' bind' bacterial' ligands' and' are 
Aβ' interactions' with' FPRLS1' lead' to' internalization' and' cell' activation' leading' to' the' release' of' proSinflammatory' cytokines ' [42] ,' in' addition' FPRLS1' has' been' shown' to' be' expressed' at' a' high' level' on' phagocytes' surrounding'fibrillar'Aβ'plaques'in'AD'patient' brain' sections,' which' suggests' FPRLS1' is' involved' in' the' uptake' of' Aβ' by ' microglia,' and'their'subsequent'activation'[43] .' ! TollKlike!Receptors' Members' of' the' family' of' these' evolutionarily'conserved'receptors'expressed' on' microglia' have' been' shown' to' bind' Aβ,' most' recently' TLRS4 ' and' TLRS6' in' combination' with' CD36' [40] .' ' An' AD' mouse' model'also'deficient'in'TLRS4'has'an'increase' in' Aβ' deposition' and' cognitive' decline,' [44]' demonstrating' a' role' for' TLRs' in' Aβ' removal' from' the' brain.' ' TLRS2' and' TLRS4' coupled' with'CD14'was'also'shown'to'bind'to'fibrillar' Aβ,' and' initiate' intracellular' signaling' through' the' SrcSVavSRac' pathway' leading' to' ROS' production' and' phagocytosis' by' microglia' [45] .' ' A' recent' study' in' human' patients' showed' an' increase' in' TLRS2' and' TLRS4' expression' and' protein' levels' on' circulating' monocytes' in' AD' affected' individuals'compared'with'controls' [46] .' ! Complement!receptors' Complement' components' are' part' of' the' phagocytic' defense' against' invading' pathogens.' ' Studies' with' microglia' in" vitro" showed'the'complement'component'C3' and'CD11b'mediate'uptake'of'fibrillar'Aβ'and' Aβ' taken' from' AD' patient' brains,' and' transport' it' to' the' lysosomes.' ' Inhibiting' phagocytosis'by'knocking'down'C3'decreased' Aβ' uptake' by' microglia.' ' When' fluorescent' fibrillar' Aβ' was' injected' into' C3' deficient' mice,'there'was'an'increase'in'Aβ'in'the'brain' when' compared' with' control' animals,' suggesting' complement' components' play' an' important'role'in'the'clearance'of'Aβ' [47] .' ' Aβ' binding' to' microglia' can' induce' the' generation'of'complement'components,'C1q,' C3,' C4' and' C5a,' and' stimulate' microglia' to' express' complement' receptors' including' C5R.' ' Inhibiting' C5R' with' pharmacological' agents' inhibited' Aβ' plaque' formation' and' reduced' microglial' activation' around' 50%' in' a'recent'study.''These'finding'also'correlated' with' improvements' in' cognitive' functions' in' two' different' AD' models' in' mice ' [48] .'' Inhibitors' of' complement' also' contribute' to' the' development' of' AD.' CD59,' which' can' prevent' formation' of' the' membrane' attack' complex' (MAC),' was' decreased' in' AD' patients'compared'with'controls.'In'contrast,' C9,' the' terminal' MAC' component' was' increased' in' AD' brains' [49] .' CD59' mRNA' expression'can'also'be'downregulated'by'Aβ,' suggesting' a' mechanism' by' which' Aβ' regulates' complement' activity' in' the' AD' brain' [50] .' ' ' Aβ!degrading!enzymes!released!by!microglia' There' have' been' several' enzymes' identified' that' degrade' Aβ,' these' include' the' zinc' metalloendopeptidases'neprilysin,'ECES1'and' ECES2' (endothelinSconverting' enzyme),' and' the' related' enzymes,' IDE' (insulinSdegrading' enzyme) ' and' MMP9' (matrix' metalloendopeptidaseS9)' [51] .'Cathepsin'B,'a' cysteine' protease' has' also' been' shown' to' degrade' Aβ' within' the' endosomes,' where' internalization' and' processing' of' APP' occurs' [52] .' ' Neprilysin' is' the' most' potent' Aβ' degrading' enzyme' expressed' in' the' brain ' [53] ,' capable' of'degrading'monomers'and'oligomers'of'Aβ' [54] .' ' In' an' AD' mouse' model' deficient' in' neprilysin,'an'increase'in'Aβ'plaques,'ADSlike' pathology' and' memory' loss' were' observed' [55] .''However,'in'one'study'when'neprilysin' was' overexpressed' there' was' a' reduction' in' overall' soluble' Aβ' levels' by' 50%,' but' no' prevention' of' cognitive' decline' [56] .' ' In' a' separate' study' where' neprilysin' was' overexpressed' by' neurons' in' a' transgenic' mouse' model,' an' improvement' in' memory' over' transgenic' mice' expressing' normal' levels' of' neprilysin' was' observed' [57] .' ' The' distinction' between' the' two' studies' may' be' due' to' the' differences' in' neprilysin' overexpression'constructs.' ' Matrix' metalloproteaseS9' (MMPS9)' is' an' enzyme' secreted' by' microglia' that' degrades' fibrillar ' Aβ' in" vitro" and' Aβ' plaques' in' mouse' brains' [58] .' The' enzyme' is' initially' secreted' as' a' proenzyme' and' is' cleaved' into' active' MMPS9'upon'its'release' [59] .''In'the'brains'of' AD'patients,'levels'of'MMPS9'have'also'been' shown'to'increase.''The'activity'of'MMPS9'is' regulated' by' tissue' inhibitors' of' MMPs' (TIMPs) ' [60] ,' and' MMPS9' is' induced' by' the' actions' of' inflammatory' cytokines' [61] .'' Microglia' from' transgenic' PS1APP' AD' mice' showed' a' general' decrease' in' Aβ' degrading' enzymes,' including' MMPS9' at' 14' months' of' age,' suggesting' microglia' in' aged' mice' may' have'a'defect'in'their'ability'to'clear'Aβ '[62] .' ' EndothelinSconverting'enzymeS'1'(ECES1)'has' been' shown' previously' to' degrade' Aβ' [63] .'' ECES1'is'also'expressed'by'microglia'[64],'and' overexpression' of' ECES1' in' the' transgenic' mouse' model' of' AD,' PS1APP' had' decreased' Aβ' plaque' levels' in' their' brains' [65] .' ' A' human' study' by ' Funalot' et' al' [66] ' showed' a' decrease' in' ECES1' levels' in' AD' brains' compared' with' control' patient' brains.'' However,' a' more' recent' study' comparing' control' and' AD' patients' showed' no' difference' in' ECES1' mRNA' or' protein' expression,' nor' was' there' any' difference' in' ECES1' activity' in' AD' patients.' ' In' contrast,' neprilysin'mRNA'and'protein' expression'and' enzyme' activity' was' decreased' in' the' AD' patients,' suggesting' that' neprilysin' is' the' major' protease' involved' in' Aβ' degradation' [67] .' ' InsulinSdegrading' enzyme' (IDE)' is' expressed' by' microglia' [68],' and' has' been' shown' to' decrease'in'AD'patient'brains'compared'with' control'subjects.''Transfection'of'human'cells' expressing' APP,' with' IDE,' upregulated' the' cell's' ability' to' degrade' Aβ' 1S42' soluble' and' fibrillar' forms' [69] .' Another' recent' study' showed' activated' microglia,' in' addition' to' having' an' increased' ability' to' phagocytose' Aβ'1S42'through'FPRS2,'also'upregulated'IDE' at'the'protein'level'to'degrade'Aβ' [70] .''In'a' mouse' model' of' AD' deficient' in' IDE,' a' 50%' reduction' in' Aβ' degradation' was' observed,' with' a' concomitant' increase' of' the' intracellular' signaling' domain' of' APP' [71] .'' Patients' with' sporadic' AD' were' found' to' have' doubled' the' amount' of' IDE' containing' plaques' compared' to' those' patients' with' familial' AD' which' demonstrates' potential' different' etiologies' between' the' two' forms' of'AD' [72] .' ' More'recently'a'novel'role'for'CathepsinSB,'a' protease' found' in' secretory' vesicles,' has' been'described'relating'to'the'destruction'of' oligomeric'Aβ.'In'a'study'with'mouse'primary' microglia,' internalization' of' oligomeric' Aβ' mediated' by' SRAS1' trafficked' oligomeric' Aβ' to' the' endosomes,' where' CathepsinSB' facilitated'its'destruction '[73] .'
Targeting!microglia!for!therapy'
Since' the' microglia' surrounding' Aβ' plaques' are' activated' and' engaged' in' an' inflammatory'response,'they'could'provide'a' target' for' therapies' aimed' at' reducing' inflammation,' thus' lessening' the' damage' to' surrounding' neurons' by' the' release' of' cytotoxic' mediators.' NonSsteroidal' antiS inflammatory' drug' (NSAID)' use' was' epidemiologically'studied'in'humans'with'AD.' Although' there' was' no' difference' in' Aβ' plaque' number' between' NSAIDStreated' and' controls,' there' was' a' significant' decrease' in' microglial' activation' in' the' NSAIDStreated' patients;' interestingly' NSAIDStreated' nonS diseased' individuals' also' had' a' reduction' in ' microglial'activation'[74] .''To'further'explore' the' role' of' NSAID' in' reducing' microglial' activation,' a' transgenic' mouse' model' of' AD' was'treated'with'the'NSAID'ibuprofen'over'a' 6' month' period.' ' NSAIDStreated' mice' had' decreased'ILS1β'protein'and'Aβ'plaques,'and' fewer' activated' microglia' surrounding' Aβ' plaques' compared' with' untreated' animals' [75] .' ' However,' experimental' dosing' of' NSAID' in' human' cohorts' of' AD' and' control' patients'did'not'decrease'microglia'activation' in' NSAIDStreated' patients,' suggesting' that' the' activation' stage' or' age' of' the' patients' may' influence' the' microglial' response' to' treatments' [76] .' ' Another' target' for' AD' therapy' is' TNFα,' a' cytokine' produced' by' microglia' upon' stimulation' with' Aβ' [77] .' In' AD' brains,' TNFα' overexpression' has' been' shown' and' treatment'of'transgenic'AD'model'mice'with' an' antiSTNFα' antibody' decreased' TNFα,' and' Aβ'plaque'deposition' [78] .''However,'a'study' using' triple' transgenic' AD' mice' deficient' in' TNFα' receptors' showed' an' overall' decrease' in' phagocytic' activity' of' microglia,' demonstrating' a' critical' role' for' TNFα' in' uptake' of' Aβ.' In' fact,' the' total' ablation' of' TNFα' may' contribute' to' pathogenesis' of' AD' [79] .' ' A' more' specifically' directed' approach' to'examine'the'role'of'TNFα'was'taken'with'a' study' of' transgenic' AD' mice' injected' either' with' a' lentivirus' expressing' a' dominantS negative' TNFα' inhibitor,' or' a' pharmacological' TNFα' inhibitor.' ' Both' chronic'inhibition'with'a'lentivirus'and'shortS term' inhibition' with' a' drug' decreased' Aβ' accumulation'in'the'brains'of'these'mice.'The' timing' of' TNFα' inhibition' was' such' that' ADS like' pathology' was' already' established,' in' contrast' to' a' systemic' knocking' out' of' TNFα' receptors' which' could' have' widerSranging' effects'systemically' [80] .' ' Controlling' microglial' actions' through' their' surface' receptors' is' also' currently' being' explored.' Inhibiting' the' CD36Smediated' inflammatory' signaling' pathway' initiated' by' Aβ'binding'to'CD36'could'prevent'the'release' of' cytotoxic' chemokines,' and' thus' reduce' neurodegeneration.' ' A' recent' study' by' our' group'discovered'ursolic'acid'acts'as'a'CD36S Aβ'inhibitor'through'development'and'use'of' a' highScontent' drug' screen.' ' Ursolic' acid' inhibited' the' inflammation' caused' by' CD36' intracellular' signaling' and' reduced' ROS' production'by'microglia'without'effecting'the' ability'of'the'cells'to'engulf'Aβ,'it'remains'to' be'determined'if'ursolic'acid'has'an'effect'of' the' development' of ' AD' in" vivo" [81] .' ' The' microglial' protein' ANXAS1' (annexin' A1)' is' expressed' by ' microglia, ' and' is' upregulated' during'AD.''ANXAS1'acts'as'a'bridge'between' apoptotic' neurons' expressing' phosphatidylserine,' and' FPRLS2' on' the' microglia.' ' ANXAS1' restores' the' ability ' of' microglia' to' discriminate' between' healthy' and' dying' cells,' the' capability' of' which' is' reduced'in'the'inflammatory'state'[82] .' ' Other!Cells!in!the!Brain! Microglia'interact'with'a'number'of'other'cell' types' in' the' brain,' and' development' of' AD' therapies' must' take' these' interactions' into' account. ' ' Of' particular' interest' are' interactions' with' neurons.' ' We' have' previously'shown'coSculture'of'AβSstimulated' wildStype' microglia' with' CAD' neuronal' cells' lead'to'significant'neuronal'cell'death, 'due'to' release' of' cytotoxic' nitric' oxide' species' by' the' microglia' [40] .' ' The' release' of' ROS' by' microglia' activated' by' Aβ' has' also' been' shown' to' have' an' effect' on' the' endothelial' cells'of'the'BBB. ''ROS'production'caused'loss' of' the' tight' junction' proteins' claudinS5' and' occludin' in' brain' sections' from' AD' patients,' 15"" """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""Journal"of"Postdoctoral"Research"January"2013":"10821" ' ' ' and' a' decrease' in' the' BBB' integrity' [89] . ' Astrocytes, ' the' most' abundant' cell' in' the' brain'[90] 'are'also'capable'of'binding'Aβ'and' becoming' activated.' ' These' cells' surround' senile' plaques' and' release' cytokines,' maintaining'the'inflammatory'response' [91] 'and'controlling'the'actions'of'microglia.''The' interplay' between' microglia' and' astrocyte' secretions' may' coSordinate' the' function' of' both' cell' types,' particularly' through' the' release' of' ILS1β' and' TNFα,' which' induces' other' cytokines' such' as' TGFβ.' ' TGFβ' acts' as' an'antagonist'to'ILS1β'and'TNFα,'serving'as'a' negative' feedback' to' control' the' inflammatory'state' [92] .' ! Summary' Microglia' are' an' essential' cell' of' the' brain,' not' only' do' they' provide' a' first' line' of' defense' against' invading' microSorganisms,' but' they' also' recognize' pathogenic' host' ligands'such'as'Aβ'and'tau'proteins.'The'role' of' microglia' in' AD' is' doubleSedged,' initially' microglia' are' activated' and' are' able' to' clear' away' deposits' of' Aβ' via' SRs' such' as' SRAS1,' but' become' overwhelmed' and' Aβ' plaques' are'allowed'to'form.'Perhaps'this'is'due'to'a' change'in'phenotype'as'we'age,'resulting'in'a' microglial' population' that' becomes' dysregulated.' ' Figure' 2' shows' a' summary' of' the' receptors' involved' in' Aβ' clearance' and' signaling' on' microglia,' and' the' enzymes' involved'in'Aβ'degradation.' ' ' ' In'addition'to'microglia,'there'are'other'cells' in'the'brain'that'play'an'important'role'in'the' development' of' AD' pathology,' and' could' be' targets' for' therapy.' Astrocytes' are' also' capable'of'binding'and'internalizing'Aβ,'with'' a' preference' for' oligomeric' Aβ' over' fibrillar ' [83] .' These' cells' are' the' most' abundant' in' the' central' nervous' system' and' become' activated,' release' cytotoxic' chemokines,' cytokines' and' reactive' oxygen' species' (ROS) ' [84] .' TRAIL' (tumor' necrosis' factorSrelated' apoptosisSinducing' ligand)' induced' by' ROS' has'previously'been'shown'to'cause'neuronal' apoptosis' through' the' binding' of ' death' receptor' 5' and' the' activation' of' caspase' 8' [85] .''Brain'endothelial'cells'form'the'bloodS brainSbarrier'(BBB),'of'which'the'transport'of' molecules' across' is' regulated' by' tight' junctions.' Aβ' can' disrupt' tight' junctions' and' has'been'shown'to'decrease'the'permeability' of' endothelial' cells' in' culture' [86] .' The' scavenger' receptor' RAGE' expressed' on' endothelial' cells' has' been' shown' to' bind' Aβ' [87],'allowing'Aβ'to'cross'the'BBB'and'enter' the'brain.''In'an'AD'mouse'model'5XFAD,'Aβ' bound' to' RAGE' was' shown' to' perturb' tight' junctions' through' calcineurin' signaling' and' MMPS9' secretion' [88] .' ' A' multiSmodal' approach' considering' microglia,' astrocytes' and'endothelial'cells'will'be'required'to'fully' understand ' AD,' and' to' develop' therapies' against'this'devastating'disorder 
